Cubist Systematic Strategies’s Transmedics TMDX Stock Holding History

Cubist Systematic Strategies’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.13M	Buy	19,000 +5,400	+40%	+$632K	0.01%	1530
2025 Q2	$1.82M	Sell	13,600 -900	-6%	-$98.8K	0.01%	1602
2025 Q1	$976K	Buy	14,500 +7,400	+104%	+$509K	0.01%	1832
2024 Q4	$443K	Sell	7,100 -17,100	-71%	-$1.59M	﹤0.01%	2236
2024 Q3	$3.8M	Sell	24,200 -6,700	-22%	-$1.03M	0.02%	1004
2024 Q2	$4.65M	Buy	30,900 +13,000	+73%	+$1.56M	0.03%	825
2024 Q1	$1.32M	Buy	17,900 +10,600	+145%	+$874K	0.01%	1942
2023 Q4	$576K	Buy	7,300 +3,300	+83%	+$199K	﹤0.01%	2447
2023 Q3	$219K	Buy	4,000 +1,100	+38%	+$79.2K	﹤0.01%	2738
2023 Q2	$244K	Hold	2,900	–	–	﹤0.01%	2721
2023 Q1	$220K	Buy	+2,900	New	+$201K	﹤0.01%	3181

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's TMDX Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 164,065 shares — an estimated $11.3M sold.

Cubist Systematic Strategies first reported a position in TMDX in Q2 2019 and held it in 14 quarters. The position peaked at $10.2M in Q4 2024. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

Cubist Systematic Strategies reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 164,065 Transmedics shares in Q1 2025, an estimated $11.3M.
Cubist Systematic Strategies first reported a position in Transmedics in Q2 2019 and held it in 14 quarters.
Cubist Systematic Strategies's Transmedics position peaked at $10.2M in Q4 2024.
299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.